abstract |
Disclosed herein are nanodroplets containing (i) a tocotrienol, (ii) a tocopherol or tocotrienol covalently bonded to a polyalkylene glycol, (iii) a poloxamer, and (iv) a polyalkylene glycol. In certain aspects, the nanodroplets described herein have anti-cancer activity even in the absence of an anti-cancer agent (e.g., chemotherapeutic agents). Thus, the nanodroplets described herein can be used alone or in combination with one or more anti-cancer agents to treat cancer. The nanodroplets exhibit low toxicity, are biodegradable, and offer chemoprotective effects when administered alone or alongside traditional anti-cancer agents. Furthermore, the nanodroplets do not interfere with the efficacy of anti-cancer agents and result in a greater reduction of tumor volume when administered to subjects with cancer as compared to commercially-available products alone. |